NeoIRX trial: Immunologic induction with peri-lymphatic cytokines to enhance pembrolizumab (pembro) response in stage II/III triple-negative breast cancer (TNBC) von Page, David B., Su, Alan, Moxon, Nicole, Mellinger, Staci L., Kelly, Tracy, Conlin, Alison Katherine, Topp, Zheng Zhu, Newell, Pippa, Fredrich, Nicole, Massimino, Kristen P., Wu, Yaping, Redmond, William L, Aliabadi, Shaghayegh, Sun, Zhaoyu, Imatani, James, Stanton, Sasha E.

Volltext

Emerging contaminants: A One Health perspective von Wang, Fang, Xiang, Leilei, Sze-Yin Leung, Kelvin, Elsner, Martin, Zhang, Ying, Guo, Yuming, Pan, Bo, Sun, Hongwen, An, Taicheng, Ying, Guangguo, Brooks, Bryan W., Hou, Deyi, Helbling, Damian E., Sun, Jianqiang, Qiu, Hao, Vogel, Timothy M., Zhang, Wei, Gao, Yanzheng, Simpson, Myrna J., Luo, Yi, Chang, Scott X., Su, Guanyong, Wong, Bryan M., Fu, Tzung-May, Zhu, Dong, Jobst, Karl J., Ge, Chengjun, Coulon, Frederic, Harindintwali, Jean Damascene, Zeng, Xiankui, Wang, Haijun, Fu, Yuhao, Wei, Zhong, Lohmann, Rainer, Chen, Changer, Song, Yang, Sanchez-Cid, Concepcion, Wang, Yu, El-Naggar, Ali, Yao, Yiming, Huang, Yanran, Cheuk-Fung Law, Japhet, Gu, Chenggang, Shen, Huizhong, Gao, Yanpeng, Qin, Chao, Li, Hao, Zhang, Tong, Corcoll, Natàlia, Liu, Min, Alessi, Daniel S., Li, Hui, Brandt, Kristian K., Pico, Yolanda, Gu, Cheng, Guo, Jianhua, Su, Jianqiang, Corvini, Philippe, Ye, Mao, Rocha-Santos, Teresa, He, Huan, Yang, Yi, Tong, Meiping, Zhang, Weina, Suanon, Fidèle, Brahushi, Ferdi, Wang, Zhenyu, Hashsham, Syed A., Virta, Marko, Yuan, Qingbin, Jiang, Gaofei, Tremblay, Louis A., Bu, Qingwei, Wu, Jichun, Peijnenburg, Willie, Topp, Edward, Cao, Xinde, Jiang, Xin, Zheng, Minghui, Zhang, Taolin, Luo, Yongming, Zhu, Lizhong, Li, Xiangdong, Barceló, Damià, Chen, Jianmin, Xing, Baoshan, Amelung, Wulf, Cai, Zongwei, Naidu, Ravi, Shen, Qirong, Pawliszyn, Janusz, Zhu, Yong-guan, Schaeffer, Andreas, Rillig, Matthias C., Wu, Fengchang, Yu, Gang, Tiedje, James M.

Volltext